In November 2023, the FDA announced an investigation of CAR T-cell therapy based on several reported secondary T-cell malignancies.
Layla Sakr, 2024 PharmD Candidate
Advertisement
Articles by Layla Sakr, 2024 PharmD Candidate
Advertisement
Latest Updated Articles
Understanding the Implications of the FDA’s New Boxed Warning for CAR T-Cell TherapyPublished: February 7th 2024 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Updated Hypertension Guidelines Are Here
2
Carefully Consider Ethical Implications of Artificial Intelligence Use in Pharmacy
3
FDA Approves Reformulated Ranitidine After 5-Year Absence
4
Application of the Age-Friendly 4M’s Movement Across Different Areas of Pharmacy
5
